Search

everythinglearnresearchcommunity

for

Search:↓

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Hair growth phase and certain genes can speed up wound healing, while an inflammatory mediator can slow down new hair growth after a wound. Understanding these factors can improve tissue regeneration during wound healing.

miR-218-5p helps skin and hair growth by targeting SFRP2 and activating a specific signaling pathway.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

Epidermal stem cells create and maintain skin structures like hair and nails through specific signaling pathways and vary by location and function.

Exosomes from hair papilla cells and the Chinese medicine Liao Tuo Fang can potentially promote hair growth and could be used to develop hair growth drugs.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

FGFR2 signaling controls Merkel cell formation in different skin regions.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Innate lymphoid cells help control skin bacteria by regulating sebaceous glands.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Chronic contact eczema may help hair regrowth in alopecia areata by reducing certain immune cell movement.

Mesenchymal stem cells and their vesicles may effectively treat skin diseases, but more research is needed.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Th22 cells are essential for Tβ15-induced hair growth in mice.

Early intervention and patient education are crucial for managing alopecia areata.